Insider Transactions in Q1 2021 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Timothy C Barabe Director |
BUY
Open market or private purchase
|
Direct |
10,000
+5.24%
|
$40,000
$4.1 P/Share
|
|
Mar 18
2021
|
Peter G Traber Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.26%
|
$40,000
$4.5 P/Share
|
|
Mar 17
2021
|
Lloyd P. Johnston Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
15,128
-14.74%
|
$60,512
$4.45 P/Share
|
|
Mar 17
2021
|
Peter G Traber Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+10.2%
|
$40,000
$4.53 P/Share
|
|
Mar 02
2021
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
5,461
-2.46%
|
$21,844
$4.26 P/Share
|
|
Mar 01
2021
|
Carsten Brunn President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,937
+4.69%
|
-
|
|
Feb 11
2021
|
Lloyd P. Johnston Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,871
+30.43%
|
$0
$0.63 P/Share
|
|
Jan 04
2021
|
Carsten Brunn President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+34.23%
|
-
|
|
Jan 04
2021
|
Bradford D. Dahms Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+50.0%
|
-
|
|
Jan 04
2021
|
Lloyd P. Johnston Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+39.69%
|
-
|
|
Jan 04
2021
|
Takashi Kei Kishimoto Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+18.8%
|
-
|
|
Jan 04
2021
|
Peter G Traber Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+32.76%
|
-
|